EarlySense develops signal-processing technology, offers EverOn, a contact-free and early detection patient supervision system.
EarlySense develops signal-processing technology. The company's lead product, EverOn, a contact-free early detection patient supervision system that measures, records, displays, and alerts heart and respiration rates, as well as bed entries and exits, patient motion, and quality of sleep from under the mattress. EarlySense Ltd. was founded in 2004 and is based in Ramat Gan, Israel with a research and development facility in Israel; and marketing offices in Boston, Massachusetts.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jan 7, 2019 | Series H | $39M | 1 | — | — | Detail |
Jun 1, 2016 | Series G | $25M | 1 | Bank Hapoalim | — | Detail |
Nov 12, 2012 | Series E | $15M | 1 | — | — | Detail |
Jul 23, 2010 | Series C | $13M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Bank Hapoalim | Yes | Series G |
Argo Capital Partners | — | Series H |
Bridge Investment Fund | — | Series E |